A systematic review of validated methods for identifying transfusion-related ABO incompatibility reactions using administrative and claims data

Pharmacoepidemiology and Drug Safety

Volumn 21, Issue SUPPL. 1, 2012, Pages 230-235

  Carnahan, Ryan M ^a   Kee, Vicki R ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

ABO incompatibility; Administrative data; International Classification of Diseases; Sensitivity; Transfusion; Validity

Indexed keywords

ARTICLE; BILLING AND CLAIMS; BLOOD GROUP ABO INCOMPATIBILITY; BLOOD GROUP TYPING; BLOOD TRANSFUSION; BLOOD TRANSFUSION REACTION; ERYTHROCYTE TRANSFUSION; HOSPITAL BILLING; HOSPITAL PATIENT; HUMAN; INTERNATIONAL CLASSIFICATION OF DISEASES; PATIENT SAFETY; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SYSTEMATIC REVIEW; VALIDATION STUDY;

ABO BLOOD-GROUP SYSTEM; ALGORITHMS; BLOOD GROUP INCOMPATIBILITY; BLOOD TRANSFUSION; CANADA; DATABASES, FACTUAL; HUMANS; INSURANCE CLAIM REVIEW; INTERNATIONAL CLASSIFICATION OF DISEASES; SENSITIVITY AND SPECIFICITY; UNITED STATES; VALIDATION STUDIES AS TOPIC;

EID: 84856025706     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.2325     Document Type: Article

References (12)

1. Dzik WH. Emily Cooley Lecture 2002: transfusion safety in the hospital. Transfusion 2003; 43: 1190-1199.
2. Baele PL, De Bruyere M, Deneys V, et al. Bedside transfusion errors: a prospective survey by the Belgium SANGUIS Group. Vox Sang 1994; 66: 117-121.
3. Janatpour KA, Kalmin ND, Jensen HM, Holland PV. Clinical outcomes of ABO-incompatible RBC transfusions. Am J Clin Pathol 2008; 129: 276-281.
4. Carnahan RM, Moores KG. Mini-Sentinel's systematic reviews of validated methods for identifying health outcomes using administrative data: methods and lessons learned. Pharmacoepidemiol Drug Saf 2012; 21(S1): 82-89.
5. Scanlon MC, Harris JM, Levy F, Sedman A. Evaluation of the Agency for Healthcare Research and Quality pediatric quality indicators. Pediatrics 2008; 121: e1723-e1731.
6. Drösler S. Facilitating Cross-National Comparisons of Indicators for Patient Safety at the Health-System Level in the OECD Countries. OECD Health Technical Papers No. 19. [accessed 30 August 2010].
7. Morton J, Anastassopoulos KP, Patel T, et al. Frequency and outcomes of blood products transfusion across procedures and clinical conditions warranting inpatient care: an analysis of the 2004 Healthcare Cost and Utilization Project Nationwide Inpatient Sample database. Am J Med Qual 2010; 25(4): 289-296.
8. Segal JB, Ness PM, Powe NR. Validating billing data for RBC transfusions: a brief report. Transfusion 2001; 41: 530-533.
9. Romano PS, Mark DH. Bias in coding of hospital discharge data and its implications for quality assessment. Med Care 1994; 32(1): 81-90.
10. Anderson S, Menis M, O'Connell K, Burwen DR. Blood use by inpatient elderly population in the United States. Transfusion 2007; 47: 582-592.
11. Menis M. Proposed changes to ICD-9-CM: transfusion associated adverse events. Presented September 17, 2009, at the ICD-9-CM Coordination and Maintenance Committee Meeting. [accessed 1 September 2010].
12. Centers for Disease Control and Prevention: National Healthcare Safety Network: Biovigilance Component. [accessed 6 September 2011].